公开(公告)号：US10786533B2

公开(公告)日：2020-09-29

申请号：US15744744

申请日：2016-07-15

申请人： Juno Therapeutics, Inc.

发明人： Kendall M. Mohler ,  Hyam I. Levitsky ,  Blythe Sather

IPC分类号： A01N63/00 ,  C12N5/071 ,  C07H21/02 ,  C07K14/00 ,  A61K35/17 ,  C12N5/0783 ,  C12N15/86 ,  C07K14/435 ,  C12N5/078

摘要： Provided are engineered cells for adoptive therapy, including NK cells and T cells. Also provided are compositions for engineering and producing the cells, compositions containing the cells, and methods for their administration to subjects. In some embodiments, the cells contain genetically engineered antigen receptors that specifically bind to antigens, such as chimeric antigen receptors (CARs) and costimulatory receptors. In some embodiments, the cells include receptors targeting multiple antigens. In some embodiments, the cells include repression of one or more gene product, for example, by disruption of a gene encoding the gene product. In some embodiments, a gene encoding an antigen recognized by the engineered antigen receptor is disrupted, reducing the likelihood of targeting of the engineered cells. In some embodiments, the antigen recognized by the engineered antigen receptor is related to a tumor antigen recognized by the engineered antigen receptor.